Researchers
Stojković-Burić, Sonja
Type
Date issued
Results 41-60 of 61
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2014 | Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy![]() | Milosevic, Zorica | Article | 22M22 |
| 2014 | Lower antioxidant capacity of P-glycoprotein overexpressing multi-drug resistant cancer cells as a mechanism for collateral sensitivity to protoflavones | Stanković, Tijana | Conference Paper | Mp. category will be shown later |
| 2014 | In silico glioma models: what can we take advantage for the clinical practice? | Alicia Martínez-González; J. Frontinan; J.M. Ayuso Dominguez; F.J. Alcain; L.A. Perez Romasanta; M. Garcia-Rojo; G.F. Calvo; I. Ochoa; Stojković, Sonja
M. Duran-Prado; V.M. Perez-Garcia;
| Conference Paper | Mp. category will be shown later |
| 2014 | Antioxidative Activity of Diarylheptanoids from the Bark of Black Alder (Alnus glutinosa) and Their Interaction with Anticancer Drugs![]() | Dinić, Jelena | Article | 21M21 |
| 2014 | Identification of potential molecular markers for cancer progression and disease outcome | Zorica Milosevic; Pešić, Milica | Conference Paper | Mp. category will be shown later |
| 2014 | Two structurally distinct chalcone dimers from Helichrysum zivojinii and their activities in cancer cell lines![]() | Aljančić, Ivana | Article | 21aM21a |
| 2014 | Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells![]() | Novaković, Miroslav M. | Article | 21aM21a |
| 2014 | Survival of patients with specific molecular profile of non-small cell lung carcinoma and neoadjuvant chemotherapy![]() | J. Stojsic; Stanković, Tijana | Conference Paper | Mp. category will be shown later |
| 2014 | Evaluating the Mechanisms of New Anticancer Agents in Multi-Drug Resistant Cancer Cells | Banković, Jasna | Conference Paper | Mp. category will be shown later |
| 2014 | Multi-drug resistant cancer cell lines as a tool for development of new therapeutic strategies | Podolski-Renić, Ana | Conference Paper | Mp. category will be shown later |
| 2013 | Anti-cancer activity of new marine quinone avarone mimetics in human multi-drug resistant non-small cell lung carcinoma cells | Dinić, Jelena | Conference Paper | Mp. category will be shown later |
| 2013 | Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing![]() | Podolski-Renić, Ana | Article | 21M21 |
| 2013 | Uloga povišene koncentracije slobodnih radikala u rezistenciji na karmustin i cisplatin kod pacovskih gliomskih C6 ćelija | Stojković, Sonja | Conference Paper | Mp. category will be shown later |
| 2013 | The Modulation Of Apoptosis During Development Of Drug-Resistance In rat C6 Glioma Cells | Stojković, Sonja | Conference Paper | Mp. category will be shown later |
| 2013 | Nove strategije u prevazilaženju višestruke rezistencije na hemioterapiju kod glioblastoma | Podolski-Renić, Ana | Conference Paper | Mp. category will be shown later |
| 2013 | Ras inhibitor-Tipifarnib modulates multidrug resistance in human cancer cell lines through inhibition of P-glycoprotein | Stojković, Sonja | Conference Paper | Mp. category will be shown later |
| 2013 | Loss of heterozygosity of PTEN in patients with non-small cell lung cancer treated and not treated with neoadjuvant chemotherapy | Stojsić, Jelena; Milinković, Vedrana P.; Stojković, Sonja | Conference Paper | Mp. category will be shown later |
| 2013 | Molecular And Cytogenetic Changes In Human Glioma Cell Line Caused By Development Of Multi-Drug Resistant Phenotype | Banković, Jasna | Conference Paper | Mp. category will be shown later |
| 2013 | Anti-Glioma Effect Of Purine Nucleoside Analog-Sulfinosine | Pešić, Milica | Conference Paper | Mp. category will be shown later |
| 2013 | Antioksidativna i citoprotektivna aktivnost diarilheptanoida iz kore Alnus glutinosa | Dinić, Jelena | Conference Paper | Mp. category will be shown later |
